Should anti-TNF-α drug levels and/or anti-drug antibodies be assayed in patients treated for rheumatoid arthritis?

Joint Bone Spine. 2012 Mar;79(2):109-12. doi: 10.1016/j.jbspin.2011.11.004. Epub 2012 Feb 20.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Antibodies, Anti-Idiotypic / blood*
  • Antirheumatic Agents / blood*
  • Antirheumatic Agents / immunology*
  • Antirheumatic Agents / therapeutic use
  • Arthritis, Rheumatoid / blood
  • Arthritis, Rheumatoid / drug therapy*
  • Arthritis, Rheumatoid / immunology
  • Dose-Response Relationship, Drug
  • Drug Antagonism
  • Drug Tolerance
  • Drug-Related Side Effects and Adverse Reactions
  • Humans
  • Treatment Outcome
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors*

Substances

  • Antibodies, Anti-Idiotypic
  • Antirheumatic Agents
  • Tumor Necrosis Factor-alpha